News

SAN DIEGO, March 27, 2026 (GLOBE NEWSWIRE) — AnaptysBio, Inc. (Nasdaq: ANAB) today announced that its planned spin-off, First Tracks Biotherapeutics, Inc. (“First Tracks Bio”), and EcoR1 Capital (the “Selling Stockholder”) have entered into a […]

SAN DIEGO–(BUSINESS WIRE)–SEQSTER PDM, Inc. (“SEQSTER”), the leading healthcare technology company powering the connection, collection, and orchestration layer of patient health data, today launched 1-Click Eligibility, an AI solution that helps research teams identify eligible […]

LA JOLLA, Calif.–(BUSINESS WIRE)– #Biopsy–Virchow Medical raises $4M seed financing led by Cerberus Ventures to advance biopsy specimen stewardship and expand access to precision oncology. Click here to view original post Click Here to Publish/Feature […]

SAN DIEGO–(BUSINESS WIRE)–iXCells Biotechnologies (“iXCells”), a leading provider of human cell-based solutions and custom iPSC services, today announced it has entered an international collaboration with Rosebud Biosciences (“Rosebud”), Kantify, and Incite to evaluate off-target chemotherapeutic […]

SAN DIEGO, March 24, 2026 (GLOBE NEWSWIRE) — Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, today announced a partnership with Avance Clinical, […]

SAN DIEGO & WATERTOWN, Mass.–(BUSINESS WIRE)–Artis BioSolutions (“Artis”), an advanced therapies company dedicated to integrating the specialized technologies, infrastructure, and manufacturing capabilities required to deliver next-generation genetic medicines, today announced the establishment of new synthetic […]

SAN DIEGO–(BUSINESS WIRE)– #EarthMonitoring–Skeyeon, Inc., today announced that the United States Patent and Trademark Office has issued U.S. Patent No. 12,559,451 B2, titled “System for Producing Remote Sensing Data from Near Earth Orbit.” The patent, […]

CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #LineageCellTherapeutics–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel allogeneic, or “off the shelf”, cell therapies for serious medical conditions, today announced the expansion of […]

SAN DIEGO–(BUSINESS WIRE)–Sinopia Biosciences, Inc., a biotechnology company advancing novel therapeutics identified using its proprietary LEADS® (LEarn And DiScover) drug discovery platform, today announced it has been awarded a research grant from the National Cancer […]

Artis BioSolutions, an advanced therapies company in San Diego, established new synthetic DNA manufacturing capabilities in Boston utilizing Bilbao, Spain-based Syngoi Technologies’ proprietary enzymatic platform. This expansion strategically extends Artis’ regional capabilities, integrating with their […]

ATLANTA–(BUSINESS WIRE)–UL Research Institutes’ Chemical Insights’ scientists will share findings from their safety science research portfolio across more than 16 presentations, sessions and events during the Society of Toxicology’s (SOT) 65th Annual Meeting and ToxExpo […]

SOUTH SAN FRANCISCO, Calif., March 23, 2026 (GLOBE NEWSWIRE) — Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, today announced […]

Salutations from San Diego. This is Jonathan Wosen, West Coast biotech & life sciences reporter. We’ve got an outstanding lineup for you today, featuring a look at the tricky choice facing federal officials on vaccine […]

SAN DIEGO, March 20, 2026 (GLOBE NEWSWIRE) — Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that the Company will […]

Life sciences developer and operator IQHQ is facing increasing financial challenges as its creditors place additional pressures on the San Diego-based company in a tough lab leasing environment.  Six registered funds with $707M allocated to IQHQ marked down […]